Literature DB >> 6279050

Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.

D S Charney, G R Heninger, D E Sternberg, K M Hafstad, S Giddings, D H Landis.   

Abstract

Several recent investigations have raised the possibility that the sensitivity of alpha 2-adrenergic receptor may be of etiologic importance in depression. To assess whether abnormalities in presynaptic alpha 2-adrenergic receptor exist in depressed patients not taking drugs, the effects of an alpha 2 agonist, clonidine, on plasma 3-methoxy-4-hydroxyphenelethyleneglycol (MHPG) and on blood pressure (BP) were evaluated in 15 depressed patients and 12 healthy controls of similar age. The ability of clonidine to increase growth hormone (GH) secretion was also assessed. The effect of clonidine on plasma MHPG and BP was not different between the depressed patients and controls. However, the GH response to clonidine was blunted in the depressed patients. These results suggest that in depression (1) the sensitivity of the presynaptic alpha 2-adrenergic receptor is not abnormal, and (2) the sensitivity of postsynaptic adrenergic receptors may be decreased.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279050     DOI: 10.1001/archpsyc.1982.04290030030005

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  18 in total

1.  Brain mechanisms of stress and depression in coronary artery disease.

Authors:  J Douglas Bremner; Carolina Campanella; Zehra Khan; Negar Fani; Nicole Kasher; Sarah Evans; Collin Reiff; Sanskriti Mishra; Stacy Ladd; Jonathon A Nye; Paolo Raggi; Viola Vaccarino
Journal:  J Psychiatr Res       Date:  2018-11-22       Impact factor: 4.791

2.  The effect of clonidine on plasma MHPG: evidence against tonic alpha 2-adrenoceptor control of noradrenergic function.

Authors:  D J Nutt; S G Molyneux
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Effect of lithium treatment on the GH-clonidine test in affective disorders.

Authors:  F Brambilla; M Catalano; A Lucca; E Smeraldi
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Intravenous alprazolam challenge in normal subjects. Biochemical, cardiovascular, and behavioral effects.

Authors:  E D Risby; J K Hsiao; R N Golden; W Z Potter
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 5.  G protein-coupled receptors in major psychiatric disorders.

Authors:  Lisa A Catapano; Husseini K Manji
Journal:  Biochim Biophys Acta       Date:  2006-10-03

Review 6.  Can drugs cause depression? A review of the evidence.

Authors:  S B Patten; E J Love
Journal:  J Psychiatry Neurosci       Date:  1993-05       Impact factor: 6.186

7.  Hormonal responses to clonidine and urinary MHPG in delusional and nondelusional melancholic patients: a placebo-controlled study.

Authors:  L Lykouras; M Markianos; J Hatzimanolis; D Malliaras; C Stefanis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

Review 8.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

9.  Evidences of a sympatho-adrenal dysfunction after lesion of the central noradrenergic pathways in rats.

Authors:  L Barbeito; C Fernández; R Silveira; F Dajas
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

10.  Comparison of the efficacy of buprenorphine and clonidine in detoxification of opioid-dependents.

Authors:  Hassan Ziaaddini; Mansooreh Nasirian; Nouzar Nakhaee
Journal:  Addict Health       Date:  2012 Summer-Autumn
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.